enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial

Go back to enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
(NASDAQ: NVNO) Delayed: 10.60 -0.03 (0.28%)
Previous Close $10.63    52 Week High
Open $10.60    52 Week Low
Day High $10.60    P/E N/A 
Day Low $10.60    EPS
Volume 2,338